Disc Medicine IRON
NASDAQ IRON
$79.23 -0.14 (-0.18%)
As of: Sep 4, 2026 · 3:59 PM EDT

Disc Medicine (IRON) Assets (2020 - 2026)

Disc Medicine (IRON) posted quarterly Assets of $735.1 million for Q2 2026, up 10.53% year-over-year from $665.1 million in Q2 2025, and down 2.02% quarter-over-quarter from $750.2 million in Q1 2026.

Analysis

Disc Medicine (IRON) Assets (2020 - 2026) Analysis & Trends

Disc Medicine (IRON) has reported Assets for 7 consecutive years, with $735.1 million the latest figure, recorded in Q2 2026.

  • In Q2 2026, Assets rose 10.53% year-over-year to $735.1 million; the TTM figure through Jun 2026 stood at $735.1 million (up 10.53% YoY), while the FY2025 annual figure was $806.9 million, up 62.42% from the prior year.
  • Assets declined to $735.1 million in Q2 2026 per IRON's latest filing, from $750.2 million in the prior quarter.
  • Across five years, Assets topped out at $806.9 million in Q4 2025 and bottomed at $106.0 million in Q3 2022.
  • Historically, Assets has averaged $448.3 million across 5 years, with a median of $439.7 million in 2023.
  • Annual changes were most pronounced in 2022 — Assets tumbled 34.37% — and 2023, when it soared 255.08%.
  • Disc Medicine's Assets stood at $200.2 million in 2022, then jumped by 83.81% to $368.0 million in 2023, then soared by 34.99% to $496.8 million in 2024, then jumped by 62.42% to $806.9 million in 2025, then dropped by 8.9% to $735.1 million in 2026.
  • Business Quant data shows IRON's Assets at $735.1 million in Q2 2026, $750.2 million in Q1 2026, and $806.9 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 27.42 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 41.73 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 10.03 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 10.96 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 4.32 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 9.18 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 5.56 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 19.82 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 2.10 Bn
10 Disc Medicine 3.06 Bn 3.06 Bn - 735.07 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 735.07 Mn
Mar 31, 2026 750.21 Mn
Dec 31, 2025 806.88 Mn
Sep 30, 2025 630.46 Mn
Jun 30, 2025 665.06 Mn
Mar 31, 2025 709.27 Mn
Dec 31, 2024 496.77 Mn
Sep 30, 2024 495.15 Mn
Jun 30, 2024 510.22 Mn
Mar 31, 2024 354.18 Mn
Dec 31, 2023 368.00 Mn
Sep 30, 2023 376.50 Mn
Jun 30, 2023 384.17 Mn
Mar 31, 2023 243.78 Mn
Dec 31, 2022 200.21 Mn
Sep 30, 2022 106.03 Mn
Jun 30, 2022 113.33 Mn
Mar 31, 2022 124.29 Mn
Dec 31, 2021 92.41 Mn
Sep 30, 2021 155.54 Mn